CLASS II ONGOING Device recall · Reported 31 Dec 2025 · FDA Enforcement Report

Affixus Antegrade Femoral Nailing System Affixus Antegrade recalled

Zimmer is recalling Affixus Antegrade Femoral Nailing System Affixus Antegrade Femoral Nails, distributed nationwide in the US. The recall was initiated on 2 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: Model No 815609360 ; UDI-DI (01)00887868144493(17)340820(10)66717603 ; Lot Number 66717603 Model No 815609360 ; UDI-DI (01)00887868144493(17)340905(10)66892902 ; Lot Number 66892902 Model No 815609360 ; UDI-DI (01)00887868144493(17)341030(10)67031550 ; Lot Number 67031550
Quantity recalled24

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0977-2026
FDA event ID
98069
Recalling firm
Zimmer, Warsaw, IN
Classification
Class II
Status
Ongoing
Recall initiated
2 Dec 2025
FDA classified
22 Dec 2025
Reported
31 Dec 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

2 Dec 2025Recall initiated by company
22 Dec 2025Classified by FDA+20 days
31 Dec 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815609360 Software Version: N/A Product Description: Affixus 9 mm, Length 360 mm, Left, Trochanteric Nail Component: N/A

Where it was distributed

US Nationwide distribution in the states of AL, AZ, CA, FL, IN, KY, MA, MO, MT, NC, NM, RI, TX, UT.

Nationwide AlabamaArizonaCaliforniaFloridaIndianaKentuckyMassachusettsMissouriMontanaNorth CarolinaNew MexicoRhode IslandTexasUtah

Questions about this recall

Is Affixus Antegrade Femoral Nailing System Affixus Antegrade Femoral Nails recalled?

Yes. Zimmer recalled Affixus Antegrade Femoral Nailing System Affixus Antegrade Femoral Nails on 2 Dec 2025. The recall is Class II and its status is Ongoing. Recall number Z-0977-2026.

Why was it recalled?

Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention.

Which lots are affected?

Lot Code: Model No 815609360 ; UDI-DI (01)00887868144493(17)340820(10)66717603 ; Lot Number 66717603 Model No 815609360 ; UDI-DI (01)00887868144493(17)340905(10)66892902 ; Lot Number 66892902 Model No 815609360 ; UDI-DI (01)00887868144493(17)341030(10)67031550 ; Lot Number 67031550

Where was it sold?

US Nationwide distribution in the states of AL, AZ, CA, FL, IN, KY, MA, MO, MT, NC, NM, RI, TX, UT.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zimmer

All 539

Other Hip & Knee Implants recalls

All 3,097